Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries

Sang Gune K. Yoo*, Grace S. Chung, Bahendeka K Silver, Abla M. Sibai , Albertino Damasceno , Farshad Farzadfar, Peter Rohloff, Corine Houehanou, Bolormaa Norov, Khem B Karki, Mohammadreza Azangou-Khyavy, Maja-Emilia Marcus , Krishna K Aryal, Luisa CC Brant, Michaela Theilmann, Renata Cifkova, Nuno Lunet, Mongal Singh Gurung, Joseph Kibachio Mwangi, Joao S MartinsRosa Haghshenas, Lela Sturua, Sebastian Vollmer, Till Bärnighausen, Rifat Atun, Jeremy B Sussman, Kavita Singh, Sahar Saeedi Moghaddam, David Guwatudde, Pascal Geldsetzer, Jennifer Manne-Goehler, Mark D. Huffman, Justine Davies, David Flood

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries'. Together they form a unique fingerprint.

Medicine & Life Sciences